Stay updated on Brexanolone in COVID-19 ARDS Clinical Trial
Sign up to get notified when there's something new on the Brexanolone in COVID-19 ARDS Clinical Trial page.

Latest updates to the Brexanolone in COVID-19 ARDS Clinical Trial page
- Check6 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3; no impact on study data or user-facing content.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedAdded a new site revision entry Revision: v3.4.2. Removed the notification about government funding lapses and the earlier Revision: v3.4.1.SummaryDifference0.4%

- Check42 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and the NIH Clinical Center's status. Updated the page version to v3.4.1, replacing v3.4.0.SummaryDifference0.4%

- Check49 days agoChange DetectedAdded a 'Show glossary' option and a new 'Revision: v3.4.0' label, while older labels such as 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data' were removed. These are cosmetic UI and labeling changes and do not affect the study data or core information.SummaryDifference0.2%

- Check63 days agoChange DetectedRevision: v3.3.4 was added to the Study Documents, replacing Revision: v3.3.3. This suggests updated study documents, such as the Protocol and Statistical Analysis Plan, are now referenced on the page.SummaryDifference0.1%

- Check84 days agoChange DetectedNew study locations added across several states (California, Georgia, Massachusetts, Michigan, Nevada, North Carolina, Virginia, and Washington). Existing state location sections were removed.SummaryDifference1.0%

Stay in the know with updates to Brexanolone in COVID-19 ARDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Brexanolone in COVID-19 ARDS Clinical Trial page.